166 related articles for article (PubMed ID: 38019417)
21. Acute kidney injury after allogeneic hematopoietic stem cell transplantation - Predictors and survival impact: A single center retrospective study.
Menezes MDM; Marques AI; Chuva T; Pinho Vaz C; Ferreira H; Branca R; Paiva A; Campos A; Maximino Costa J
Nefrologia (Engl Ed); 2022; 42(6):656-663. PubMed ID: 36402680
[TBL] [Abstract][Full Text] [Related]
22. Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.
Renaghan AD; Jaimes EA; Malyszko J; Perazella MA; Sprangers B; Rosner MH
Clin J Am Soc Nephrol; 2020 Feb; 15(2):289-297. PubMed ID: 31836598
[TBL] [Abstract][Full Text] [Related]
23. Acute kidney injury and risk factors in pediatric patients undergoing hematopoietic stem cell transplantation.
Avcı B; Bilir ÖA; Özlü SG; Kanbur ŞM; Gökçebay DG; Bozkaya İO; Bayrakçı US; Özbek NY
Pediatr Nephrol; 2024 Jul; 39(7):2199-2207. PubMed ID: 38324191
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for severe acute kidney injury after pediatric hematopoietic cell transplantation.
Bauer A; Carlin K; Schwartz SM; Srikanthan M; Thakar M; Burroughs LM; Smith J; Hingorani S; Menon S
Pediatr Nephrol; 2023 Apr; 38(4):1365-1372. PubMed ID: 36125547
[TBL] [Abstract][Full Text] [Related]
25. The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma.
Jaglowski SM; Ruppert AS; Hofmeister CC; Elder P; Blum W; Klisovic R; Vasu S; Penza S; Efebera YA; Benson DM; Devine SM; Andritsos LA
Bone Marrow Transplant; 2014 Oct; 49(10):1323-9. PubMed ID: 25068419
[TBL] [Abstract][Full Text] [Related]
26. Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation.
Kizilbash SJ; Kashtan CE; Chavers BM; Cao Q; Smith AR
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1264-1270. PubMed ID: 27034153
[TBL] [Abstract][Full Text] [Related]
27. Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.
Hosing C; Nash R; McSweeney P; Mineishi S; Seibold J; Griffith LM; Shulman H; Goldmuntz E; Mayes M; Parikh CR; Crofford L; Keyes-Elstein L; Furst D; Steen V; Sullivan KM
Biol Blood Marrow Transplant; 2011 May; 17(5):674-81. PubMed ID: 20708086
[TBL] [Abstract][Full Text] [Related]
28. Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Fabre C; Koscielny S; Mohty M; Fegueux N; Blaise D; Maillard N; Tabrizi R; Michallet M; Socié G; Yakoub-Agha I; Garban F; Uzunov M; François S; Contentin N; Lapusan S; Bourhis JH
Haematologica; 2012 Apr; 97(4):482-90. PubMed ID: 22058218
[TBL] [Abstract][Full Text] [Related]
29. Edentulism and transplant-associated complications in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.
Toro JJ; Gushiken FC; Schneider D; Lee S; Haile DJ; Freytes CO
Support Care Cancer; 2016 Aug; 24(8):3411-5. PubMed ID: 26984247
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for acute kidney injury in pediatric patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Huang B; Shan J; Yi L; Xin Y; Zhong Z; Xu H
Pediatr Nephrol; 2024 Feb; 39(2):397-408. PubMed ID: 37079103
[TBL] [Abstract][Full Text] [Related]
31. Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis.
Irazabal MV; Eirin A; Gertz MA; Dispenzieri A; Kumar S; Buadi FK; Lacy MQ; Hayman SR; Dingli D; Hogan WJ; Gastineau DA; Glavey SV; Amer H; Leung N
Am J Hematol; 2012 Jan; 87(1):51-4. PubMed ID: 22076913
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation.
Berro M; Arbelbide JA; Rivas MM; Basquiera AL; Ferini G; Vitriu A; Foncuberta C; Fernandez Escobar N; Requejo A; Milovic V; Yantorno S; Szelagoswki M; Martinez Rolon J; Bentolila G; Garcia JJ; Garcia P; Caeiro G; Castro M; Jaimovich G; Palmer S; Trucco JI; Bet LA; Shaw BE; Kusminsky GD
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1646-1650. PubMed ID: 28669923
[TBL] [Abstract][Full Text] [Related]
33. Acute Kidney Injury in Children after Hematopoietic Cell Transplantation Is Associated with Elevated Urine CXCL10 and CXCL9.
Erez DL; Denburg MR; Afolayan S; Jodele S; Wallace G; Davies SM; Seif AE; Bunin N; Laskin BL; Sullivan KE
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1266-1272. PubMed ID: 32165324
[TBL] [Abstract][Full Text] [Related]
34. A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis.
Piñana JL; Perez-Pitarch A; Garcia-Cadenas I; Barba P; Hernandez-Boluda JC; Esquirol A; Fox ML; Terol MJ; Queraltó JM; Vima J; Valcarcel D; Ferriols-Lisart R; Sierra J; Solano C; Martino R
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1177-1185. PubMed ID: 28396159
[TBL] [Abstract][Full Text] [Related]
35. Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.
Tosi P; Zamagni E; Ronconi S; Benni M; Motta MR; Rizzi S; Tura S; Cavo M
Leukemia; 2000 Jul; 14(7):1310-3. PubMed ID: 10914557
[TBL] [Abstract][Full Text] [Related]
36. Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.
Shah N; Cornelison AM; Saliba R; Ahmed S; Nieto YL; Bashir Q; Parmar S; Hosing C; Popat U; Shpall EJ; Champlin RE; Qazilbash M
Eur J Haematol; 2017 Dec; 99(6):532-535. PubMed ID: 28895206
[TBL] [Abstract][Full Text] [Related]
37. Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipients.
Lopedote P; Xue E; Chotivatanapong J; Pao EC; Wychera C; Dahlberg AE; Thur L; Roberts L; Baker K; Gooley TA; Hingorani S; Milano F
Front Oncol; 2023; 13():1186503. PubMed ID: 37260983
[TBL] [Abstract][Full Text] [Related]
38. Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
Varma A; Biritxinaga L; Saliba RM; Stich M; Jauch SF; Afrough A; Honhar M; Popat UR; Shafi MA; Shah N; Bashir Q; Dinh Y; Hosing C; Champlin RE; Qazilbash MH
Biol Blood Marrow Transplant; 2017 Apr; 23(4):581-587. PubMed ID: 28063964
[TBL] [Abstract][Full Text] [Related]
39. Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors.
Wu NL; Hingorani S; Cushing-Haugen KL; Lee SJ; Chow EJ
Transplant Cell Ther; 2021 May; 27(5):434.e1-434.e6. PubMed ID: 33775588
[TBL] [Abstract][Full Text] [Related]
40. Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant.
Chen J; Seabrook J; Fulford A; Rajakumar I
J Oncol Pharm Pract; 2017 Mar; 23(2):116-120. PubMed ID: 26684614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
